Joseph P. Lyssikatos

Insider Reports History

Entity
Individual
Location
6200 Lookout Road, Boulder, CO
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph P. Lyssikatos:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 1.02M $30.5M $30.00 Oct 18, 2024 Indirect
Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (right to buy) 171K Feb 6, 2025 Direct

Insider Reports Filed by Joseph P. Lyssikatos

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELVN Enliven Therapeutics, Inc. Feb 6, 2025 1 $0 4 Feb 10, 2025 CHIEF SCIENTIFIC OFFICER
ELVN Enliven Therapeutics, Inc. Oct 18, 2024 1 -$25.4K 4 Oct 22, 2024 CHIEF SCIENTIFIC OFFICER
ELVN Enliven Therapeutics, Inc. Oct 8, 2024 4 -$1.44M 4 Oct 10, 2024 CHIEF SCIENTIFIC OFFICER
ELVN Enliven Therapeutics, Inc. Oct 4, 2024 2 -$282K 4 Oct 8, 2024 CHIEF SCIENTIFIC OFFICER
ELVN Enliven Therapeutics, Inc. Oct 1, 2024 1 -$14.5K 4 Oct 3, 2024 CHIEF SCIENTIFIC OFFICER
ELVN Enliven Therapeutics, Inc. Aug 29, 2024 2 -$270K 4 Sep 3, 2024 CHIEF SCIENTIFIC OFFICER
ELVN Enliven Therapeutics, Inc. Jul 31, 2024 1 -$85.4K 4 Aug 2, 2024 CHIEF SCIENTIFIC OFFICER
ELVN Enliven Therapeutics, Inc. Jul 29, 2024 2 -$320K 4 Jul 31, 2024 CHIEF SCIENTIFIC OFFICER
ELVN Enliven Therapeutics, Inc. Jul 1, 2024 1 -$275K 4 Jul 3, 2024 CHIEF SCIENTIFIC OFFICER
ELVN Enliven Therapeutics, Inc. May 29, 2024 4 -$247K 4 May 31, 2024 CHIEF SCIENTIFIC OFFICER, Director
ELVN Enliven Therapeutics, Inc. Apr 29, 2024 4 -$202K 4 May 1, 2024 CHIEF SCIENTIFIC OFFICER, Director
ELVN Enliven Therapeutics, Inc. Apr 11, 2024 3 -$718K 4 Apr 15, 2024 CHIEF SCIENTIFIC OFFICER, Director
ELVN Enliven Therapeutics, Inc. Apr 1, 2024 5 -$210K 4 Apr 3, 2024 CHIEF SCIENTIFIC OFFICER, Director
ELVN Enliven Therapeutics, Inc. Feb 29, 2024 4 -$184K 4 Mar 4, 2024 CHIEF SCIENTIFIC OFFICER, Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 CHIEF SCIENTIFIC OFFICER, Director
ELVN Enliven Therapeutics, Inc. Jan 29, 2024 3 -$177K 4 Jan 31, 2024 CHIEF SCIENTIFIC OFFICER, Director
ELVN Enliven Therapeutics, Inc. Dec 29, 2023 4 -$158K 4 Jan 3, 2024 Chief Scientific Officer, Director
ELVN Enliven Therapeutics, Inc. Dec 21, 2023 6 -$78.4K 4 Dec 26, 2023 Chief Scientific Officer, Director
ELVN Enliven Therapeutics, Inc. Dec 19, 2023 6 -$106K 4 Dec 21, 2023 Chief Scientific Officer, Director
ELVN Enliven Therapeutics, Inc. Nov 3, 2023 3 -$102K 4 Nov 6, 2023 Chief Scientific Officer, Director
ELVN Enliven Therapeutics, Inc. Sep 29, 2023 3 -$150K 4 Oct 3, 2023 Chief Scientific Officer, Director
ELVN Enliven Therapeutics, Inc. Apr 4, 2023 1 $0 4 Apr 6, 2023 Chief Scientific Officer, Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 3 $0 4 Feb 27, 2023 Chief Scientific Officer, Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Chief Scientific Officer, Director